We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£140.99
This is the most expensive it has ever been. Walk away.
£141 today · previous high £141 · all-time low £124
Elsevier Academic Press - Anti-CD20 Antibody Resistance Volume 2
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 74 days · 74 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 74 days • 3 price levels
Price Analysis
Most common price: £124 (50 days, 67.6%)
Price range: £124 - £141
Price levels: 3 different prices over 74 days
Description
Key Features
This Academic Press volume focuses on the study of resistance to anti-CD20 antibodies and methods for reversal.
The text covers essential topics regarding B cell depletion and the treatment of B cell proliferative disorders.
Content includes research on managing non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
International experts contribute in-depth analysis regarding patients who fail to respond to initial therapy or experience relapse.
This book is part of the Breaking Tolerance to Antibody-Mediated Immunotherapy series, Volume 2.
Product Specifications
- Brand
- Elsevier
- Format
- hardcover
- ASIN
- 0443192006
- Domain
- Amazon UK
- Release Date
- 11 September 2023
- Listed Since
- 17 December 2022
Barcode
No barcode data available
Similar Products You Might Like
T Cell Metabolism and Cancer Immunotherapy - Academic Press
Elsevier
Immuno-oncology and Immunotherapy Part G: Volume 202 (Methods in Cell Biology, Volume 202)
Elsevier
Immuno-oncology and Immunotherapy Part D - Volume 196
Elsevier
Immuno-oncology and Immunotherapy Part F: Volume 201 (Methods in Cell Biology, Volume 201)
Elsevier
Immuno-oncology and Immunotherapy Part A - Volume 189
Elsevier
Cancer Immunotherapy (Volume 209) (Progress in Molecular Biology and Translational Science, Volume 209)
Elsevier
Immuno-oncology and Immunotherapy Part E - Volume 199
Elsevier
Advances in DNA and mRNA Cancer Immunotherapy - Volume 165
Elsevier
Academic Press Immuno-oncology and Immunotherapy Vol 190
Elsevier
Immuno-oncology and Immunotherapy Part C - Volume 191
Elsevier
T Cell Cancer Immunotherapy - Clinical Translation Guide
Elsevier
Cytokine-Based Immunotherapy Part B Volume 401 - Medical Review
Elsevier
Academic Press Cell-based Cancer Immunotherapy Vol 183
Elsevier
Immunothérapie des cancers au troisième millénaire
EDP SCIENCES
Evolution of Immunotherapy Against Tumors - Academic Press
Elsevier
Principles of Immunotherapy in Breast and Gastrointestinal Cancers: Activity, Mechanisms of Resistance and New Sensitization Strategies (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy)
Elsevier
Advances in Cancer Immunotherapy
IntechOpen
Frontiers in Cancer Immunology; Systems Biology in Cancer Immunotherapy: 2
Bentham Science Publishers
Resistance in Hematologic Malignancies and Cancer (Volume 22) (Cancer Sensitizing Agents for Chemotherapy, Volume 22)
Elsevier
Cancer Immunotherapy - Cellular Mechanisms & Therapeutic Advances
IntechOpen
Cancer Immunotherapy: Methods and Protocols: 2748 (Methods in Molecular Biology, 2748)
Humana
Cellular Therapy for Autoimmune Disease (Developments in Immunology)
Elsevier
Cancer Immunotherapy in Clinical Practice - Medical Textbook
McGraw-Hill Education
Antibodies for Treating Cancer: Basics, Development, and Applications
Springer